# Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients

> **NCT00349453** · PHASE2 · COMPLETED · sponsor: **Lipomed** · enrollment: 24 (actual)

## Conditions studied

- Hemochromatosis

## Interventions

- **DRUG:** Deferiprone (L1)
- **DRUG:** Deferiprone (L1)
- **DRUG:** Desferrioxamine

## Key facts

- **NCT ID:** NCT00349453
- **Lead sponsor:** Lipomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00349453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00349453, "Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00349453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*